Sunday, January 29, 2017

Global Strategy for the Diagnosis, Management, and Prevention of COPD (GOLD) 2017 Report published in Blue Journal

This Executive Summary of the Global Strategy for the Diagnosis, Management, and Prevention of COPD (GOLD) 2017 Report focuses primarily on the revised and novel parts of the document. 
http://www.atsjournals.org/doi/abs/10.1164/rccm.201701-0218PP
The most significant changes include: 
i) the assessment of COPD has been refined to separate the spirometric assessment from symptom evaluation. ABCD groups are now proposed to be derived exclusively from patient symptoms and their history of exacerbations; 
ii) for each of the groups A to D, escalation strategies for pharmacological treatments are proposed; 
iii) the concept of de-escalation of therapy is introduced in the treatment assessment scheme; 
iv) nonpharmacologic therapies are comprehensively presented and; 
v) the importance of comorbid conditions in managing COPD is reviewed. 
Link to full text:

Wednesday, January 25, 2017

Pneumonology Quiz – Case 4 (free article from Archives of Hellenic Medicine)

Dear friends read new Pneumology Quiz from Archives of Hellenic Medicine!
A 34-year-old female patient presented to the emergency department with 6 hours’ history of sudden onset of breathlessness associated with severe pleuritic chest pain, minimal hemoptysis and pyrexia. She denied any other symptoms. She
had only returned from a business meeting in South Africa a week ago and she was quite concerned of the possibility of having contracted a tropical infection, although she had followed vaccination and hygiene advice given by an infectious disease specialist before her departure, four weeks ago. Her past medical history included two episodes of miscarriage. On examination, she was tachycardic (95 bpm) with normal blood pressure (140/75 mmHg), tachypneic (22 bpm) with normal oxygen saturation (95% on room air) and pyrexial (37.4 oC). A detailed clinical examination did not yield positive clinical findings. Full blood count, urea and electrolytes, as well as c-reactive protein (CRP) were all within normal range. Chest X-ray was insignificant.
https://www.researchgate.net/publication/312593052_Pneumonology_Quiz_-_Case_4
Full free text:

Previous cases:

Pneumonology Quiz - Case 1

Pneumonology Quiz - Case 2

Pneumonology Quiz – Case 3

Friday, January 20, 2017

Introducing COPD Research and Practice

Dear friends we are happy to present you new Respiratory Journal: COPD Research and Practice!
http://copdrp.biomedcentral.com/
COPD Research and Practice publishes basic and clinical research and cutting edge reviews related to chronic obstructive pulmonary disease (COPD). The journal aims to facilitate discussion and dissemination of knowledge to help translate new ideas from bench to bedside by encouraging international and interdisciplinary collaboration.
Editorial from Editor in Chief Professor Mario Cazzola from the University of Rome Tor Vergata, Rome, Italy:
COPD is now the fourth leading cause of death globally, and the World Health Organization (WHO) has predicted that it will become the third most common cause of death in the world by 2030 [1]. In developed countries, current information estimates a prevalence of 8 % to 10 % among adults 40 years of age and older, whereas in developing countries, prevalence varies significantly among countries and is difficult to quote [2].
http://copdrp.biomedcentral.com/
It is estimated that more than 210 million people have the disease worldwide [3]. Concerning a large number of subjects, COPD generates important health and social costs. However, although COPD is one of the most common chronic diseases and has a high health and social impact, it is still poorly recognized among the general public and also clinicians. Consequently, there is a major and urgent need to better understand this complex disease.
Free full text:
http://copdrp.biomedcentral.com/articles/10.1186/s40749-015-0007-9

Saturday, January 14, 2017

2017 Lung Cancer Guidelines: The Eighth Edition Lung Cancer Stage Classification

Stage classification provides a nomenclature about the anatomic extent of a cancer; a consistent language provides the ability to communicate about a specific patient and about cohorts of patients in clinical studies. This paper summarizes the eighth edition of lung cancer stage classification, which is the worldwide standard as of January 1, 2017. 
http://journal.publications.chestnet.org/article.aspx?articleID=2578191

This revision is based on a large global database, a sophisticated analysis, extensive internal validation as well as multiple assessments confirming generalizability. 
http://journal.publications.chestnet.org/article.aspx?articleID=2578191

Practicing clinicians must be familiar with the stage classification system when managing contemporary patients with lung cancer.
Fulltext:

Friday, January 6, 2017

2017 ERS/ATS standards for single-breath carbon monoxide uptake in the lung

This document provides an update to the European Respiratory Society (ERS)/American Thoracic Society (ATS) technical standards for single-breath carbon monoxide uptake in the lung that was last updated in 2005. Although both DLCO (diffusing capacity) and TLCO (transfer factor) are valid terms to describe the uptake of carbon monoxide in the lung, the term DLCO is used in this document. A joint taskforce appointed by the ERS and ATS reviewed the recent literature on the measurement of DLCO and surveyed the current technical capabilities of instrumentation being manufactured around the world. The recommendations in this document represent the consensus of the taskforce members in regard to the evidence available for various aspects of DLCO measurement. 
http://erj.ersjournals.com/content/49/1/1600016
Furthermore, it reflects the expert opinion of the taskforce members on areas in which peer-reviewed evidence was either not available or was incomplete. The major changes in these technical standards relate to DLCO measurement with systems using rapidly responding gas analysers for carbon monoxide and the tracer gas, which are now the most common type of DLCO instrumentation being manufactured. Technical improvements and the increased capability afforded by these new systems permit enhanced measurement of DLCO and the opportunity to include other optional measures of lung function.
Fulltext: